We recently started looking at Double-Take's software, and everything we've seen this far suggests that it represents a great value for organizations looking to deploy an excellent, cost-effective replication infrastructure. The stock isn't as cheap… More
This company sucks. They don't have released any single good product since nearly 6 years. And lately when they released a so call new product, few months later they took it out of their portfolio.....
They are operating in a very challenging… More